美国全国样本中良性指征门诊子宫切除术成本的决定因素
该研究基于Vizient临床数据库2015年10月至2021年12月门诊子宫切除术患者,排除妇科恶性肿瘤,最终纳入264,717例、5,153名术者。子宫切除术总直接成本中位数为4,705美元,机器人子宫切除术最高(5,412美元),阴式最低(4,147美元);入路是最强的可观察预测因素,但60.5%的成本方差归因于术者层面未解释的差异。
要点
- 门诊良性指征子宫切除术总直接成本中位数4,705美元(四分位距3,522-6,234美元)。
- 机器人子宫切除术成本最高(5,412美元),阴式子宫切除术最低(4,147美元)。
- 60.5%的成本方差归因于术者层面未解释的差异,第10至90百分位术者间成本差为4,063美元。
核心结论
- 美国良性指征门诊子宫切除术成本最大的可观察决定因素是手术入路,但成本差异主要归因于术者间未解释的差异。
- 标准化手术入路和技术以及术者对手术耗材成本的认知可能解决这些未解释的成本差异。
研究设计与样本
- 研究采用混合效应回归分析,纳入术者层面随机效应以捕捉影响成本变异的未观察差异。
- 样本来自Vizient临床数据库2015年10月至2021年12月门诊子宫切除术患者,排除妇科恶性肿瘤诊断。
- 最终样本包括264,717例手术,由5,153名术者实施。
主要发现
- 子宫切除术总直接成本中位数为4,705美元(四分位距3,522-6,234美元)。
- 机器人子宫切除术成本最高(5,412美元),阴式子宫切除术成本最低(4,147美元)。
- 所有变量纳入回归模型后,入路是观察到的预测因素中最强的,但60.5%的成本方差归因于术者层面未解释的差异。
- 术者第10至90百分位之间的成本差异为4,063美元。
临床怎么用
- 原文结论提出标准化手术入路和技术以及术者对手术耗材成本的认知可能解决未解释的成本差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify surgeon-level variation in cost to produce an outpatient hysterectomy for benign indications in the United States. METHODS: A sample of patients undergoing outpatient hysterectomy in October 2015 to December 2021, excluding those with a diagnosis of gynecologic malignancy, was obtained from the Vizient Clinical Database. The primary outcome was total direct hysterectomy cost, which is a modeled cost to produce care. Patient, hospital, and surgeon covariates were analyzed with mixed-effects regression, which included surgeon-level random effects to capture unobserved differences influencing cost variation. RESULTS: The final sample included 264,717 cases performed by 5,153 surgeons. The median total direct cost of hysterectomy was $4,705 (interquartile range $3,522-6,234). Cost was highest for robotic hysterectomy ($5,412) and lowest for vaginal hysterectomy ($4,147). After all variables were included in the regression model, approach was the strongest of the observed predictors, but 60.5% of the variance in costs was attributable to unexplained surgeon-level differences, implying a difference in costs between the 10th and 90th percentiles of surgeons of $4,063. CONCLUSION: The largest observed determinant of cost to produce an outpatient hysterectomy for benign indications in the United States is approach, but differences in cost are attributable primarily to unexplained differences among surgeons. Standardization of surgical approach and technique and surgeon awareness of surgical supply costs could address these unexplained cost variations.
引用
- Whiteside JL, Tumin D, Hohmann SF, et al. Determinants of Cost for Outpatient Hysterectomy for Benign Indications in a Nationwide Sample. Obstet Gynecol. 2023. PMID: 36897129. doi:10.1097/AOG.0000000000005109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。